<DOC>
	<DOCNO>NCT03065881</DOCNO>
	<brief_summary>The primary objective study collect electroretinogram ERG measurement visually normal abnormal subject use FDA clear RETeval device ( K142567 ) . Data visually normal subject use create reference interval device . Secondary objective study provide ERG waveform representative disease state encounter analyze well ERG detect various disease state encounter .</brief_summary>
	<brief_title>RETeval All Comers Trial ( REACT )</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<criteria>All volunteer ( age 0.5 95 ) willing participate study part routine eye exam . While specifically target vulnerable group example child pregnant woman , invite participate study . Collecting normative data less represented population particularly difficult welcome opportunity gather rare data . Subjects age 18 include assent subject ( least 10 year age ) consent one parent/guardian ( age 10 ) . In case patient able provide consent him/her self willing participate study person consent routine eye exam consent REACT study . Subjects photosensitive epilepsy , allergy pupil dilate agent , history cardiac dysrhythmia invite participate study . Subjects history glaucoma either include group non dilate subject dilate ERGs dilation recommend health professional part routine eye exam . Exclusion criterion base volunteer 's provide information time sign consent form . If patient aware photosensitive epilepsy occur record , test interrupt immediately . Statistically , 1 person 3600 people suffer photosensitive epilepsy US . There rather small possibility encounter person collection ERGs group 1000 volunteer</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>